Shilpa Medicare gains 7% on EIR for Jadcherla formulations unit
newsdepo.com
The stock was 7% to Rs 488 on the BSE after the company received EIR from the USFDA for its formulation manufacturing facility in Telangana following the audit in November last year.Shilpa Medicare gains 7% on EIR for Jadcherla formulations unit
The stock was 7% to Rs 488 on the BSE after the company received EIR from the USFDA for its formulation manufacturing facility in Telangana following the audit in November last year. Read more